Intravenous Immunoglobulin and Methylprednisolone for Clozapine-Associated Perimyocarditis.
Publication/Presentation Date
1-1-2019
Abstract
CLINICAL FEATURES: Cardiotoxicity is a rare but serious side effect of clozapine. We present a case of a psychiatric patient on chronic clozapine 75 mg daily, who presented with congestive heart failure secondary to the cardiotoxic effects of the psychiatric medication.
THERAPEUTIC CHALLENGE: Conventional heart failure treatment failed to improve symptoms.
SOLUTION: A course of 40 mg of intravenous immunoglobulin and 125 mg of steroids was implemented, after which the patient made a full recovery. We hope to raise awareness of concurrent clozapine-induced pericarditis and myocarditis and propose a role of intravenous immunoglobulin and steroids in the treatment of drug-induced cardiomyopathy.
Volume
26
Issue
4
First Page
485
Last Page
485
ISSN
1536-3686
Published In/Presented At
Cheng, A., Ahmed, M., & Shuaib, W. (2019). Intravenous Immunoglobulin and Methylprednisolone for Clozapine-Associated Perimyocarditis. American journal of therapeutics, 26(4), e485–e486. https://doi.org/10.1097/MJT.0000000000000751
Disciplines
Medicine and Health Sciences
PubMedID
29659374
Department(s)
Department of Medicine
Document Type
Article